The cloning of the breast and ovarian cancer susceptibility gene, BRCA1, allows direct estimation of the proportion of these cancers in the general population which can be attributed to germline mutations in this gene. We have used a combination of SSCP, heteroduplex analysis, and chemical cleavage
Breast cancer and missense mutations in the transactivation region of the BRCA1 gene
β Scribed by J.M. Garcia; G. Dominguez; J.M. Silva; R. Gonzalez; M.A. Navarro; C. Corbacho; G. Martinez; M.J. Villanueva; F. Navarro; F. Bonilla
- Book ID
- 117666614
- Publisher
- Elsevier Science
- Year
- 1998
- Tongue
- English
- Weight
- 157 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Predisposing germline mutations in the BRCAl gene were identified recently in families with 17qlinked breast and ovarian cancers. Using single-strand conformation polymorphism (SSCP) analysis, we examined primary breast cancers for mutations in coding exons of BRCAl in a panel of 103 patients, of wh
Fifteen years ago BRCA1 and BRCA2 were reported as high penetrant breast cancer predisposing genes. However, mutations in these genes are found in only a fraction of high risk families. BARD1 is a candidate breast cancer gene, but only a limited number of missense mutations with rather unclear patho
In this study we genotyped Turkish breast/ovarian cancer patients for BRCA1/BRCA2 mutations: protein truncation test (PTT) for exon 11 BRCA1 of and, multiplex PCR and denaturing gradient gel electrophoresis (DGGE) for BRCA2, complemented by DNA sequencing. In addition, a modified restriction assay w